Esperion Therapeutics, Inc. (ESPR)

NASDAQ: ESPR · Real-Time Price · USD

3.160

+0.010 (0.32%)

At close: Jun 22, 2026, 4:00 PM EDT

3.160

0.00 (-0.01%)

After-hours: Jun 22, 2026, 7:49 PM EDT

Esperion Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	418.24	403.14	332.31	116.33	75.48	78.45
Revenue Growth (YoY)	61.13%	21.31%	185.66%	54.14%	-3.79%	-65.53%
Cost of Revenue	132.26	129.22	68.6	43.27	26.97	14.22
Gross Profit	285.99	273.91	263.71	73.07	48.51	64.23
Selling, General & Admin	165.91	165.79	163.07	142.52	109.08	184.99
Research & Development	44.28	47.85	46.24	86.11	118.93	105.98
Total Operating Expenses	210.2	213.64	209.31	228.63	228.01	290.96
Operating Income	75.79	60.27	54.4	-155.56	-179.5	-226.73
Interest Expense	-84.97	-84.6	-59.25	-58.98	-56.81	-46.35
Other Non-Operating Income (Expense)	3.6	3.49	-46.9	5.29	2.65	3.98
Total Non-Operating Income (Expense)	-81.37	-81.11	-106.15	-53.69	-54.16	-42.38
Pretax Income	63.67	-20.84	-51.75	-209.25	-233.66	-269.11
Provision for Income Taxes	1.84	1.84	-	-	-	-
Net Income	61.83	-22.68	-51.75	-209.25	-233.66	-269.11
Net Income to Common	-7.42	-22.68	-51.75	-209.25	-233.66	-269.11
Shares Outstanding (Basic)	222	208	187	103	66	29
Shares Outstanding (Diluted)	234	208	187	103	66	29
Shares Change (YoY)	20.48%	11.05%	81.54%	55.27%	129.76%	5.20%
EPS (Basic)	-0.06	-0.11	-0.28	-2.03	-3.52	-9.31
EPS (Diluted)	-0.10	-0.11	-0.28	-2.03	-3.52	-9.31
Free Cash Flow	-18.38	-13.09	-23.97	-135.49	-174.83	-263.81
Free Cash Flow Per Share	-0.08	-0.06	-0.13	-1.31	-2.63	-9.13
Gross Margin	68.38%	67.95%	79.36%	62.81%	64.27%	81.88%
Operating Margin	18.12%	14.95%	16.37%	-133.72%	-237.83%	-289.02%
Profit Margin	14.78%	-5.63%	-15.57%	-179.87%	-309.58%	-343.04%
FCF Margin	-4.39%	-3.25%	-7.21%	-116.46%	-231.64%	-336.29%
EBITDA	75.89	60.38	54.47	-155.4	-179	-226.12
EBITDA Margin	18.15%	14.98%	16.39%	-133.58%	-237.17%	-288.24%
EBIT	75.79	60.27	54.4	-155.56	-179.5	-226.73
EBIT Margin	18.12%	14.95%	16.37%	-133.72%	-237.83%	-289.02%
Effective Tax Rate	2.89%	-8.83%	0.00%	0.00%	0.00%	0.00%

SEC Filings: 10-K · 10-Q